Insider · CIK 0001702031
Gunther Birznieks
Files at VNDA (Vanda Pharmaceuticals Inc.). First filing Mar 4, 2026, latest Mar 4, 2026.
In brief
Gunther Birznieks files SEC Form 4 as officer at VNDA (Vanda Pharmaceuticals Inc.). Since Mar 4, 2026, Gunther Birznieks has reported 0 open-market buys worth $0 and 1 open-market sell worth $351k, the latest filed on Mar 4, 2026.
A track record needs three past buys with six months of prices behind them; Gunther Birznieks has 0, so none is measured yet.
The newest scored trade: sold $351k of VNDA on Mar 2, 2026, filed Mar 4, 2026, scored 45 (moderate). In the last 12 months: 0 buys worth $0 and 1 sell worth $351k.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
VNDA: Vanda Pharmaceuticals Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 45Moderate | Vanda Pharmaceuticals Inc. | $351k 42,431 shares | -8% | +108% from low-8% from high |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Mar 2, 2026 | VNDA Vanda Pharmaceuticals Inc. | 42,431 0.07% of outstanding | $351k | Mar 2, 2026 | none |
Transactions
Every row this insider has filed, 4 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Mar 2, 2026 | VNDA Vanda Pharmaceuticals Inc. | SOpen-market sale Common Stock | -42,431 | $8.27 | $351k | 494,197 | Mar 4, 2026 |
| Feb 18, 2026 | VNDA Vanda Pharmaceuticals Inc. | AGrant or award Common Stock | +125,000 | $0.00 | $0 | 536,628 | Feb 19, 2026 |
| Mar 1, 2025 | VNDA Vanda Pharmaceuticals Inc. | FTax withholding Common Stock | -26,941 | $4.76 | $128k | 411,628 | Mar 4, 2025 |
| Feb 18, 2025 | VNDA Vanda Pharmaceuticals Inc. | AGrant or award Common Stock | +125,000 | $0.00 | $0 | 438,569 | Feb 20, 2025 |
Questions about Gunther Birznieks
Answered from the filings on this page, as of the latest one.
Is Gunther Birznieks buying or selling?
In the last 12 months Gunther Birznieks reported 0 open-market buys worth $0 and 1 open-market sell worth $351k on SEC Form 4; the latest was sold $351k of VNDA on Mar 2, 2026. Grants, option exercises and tax withholding are not counted.
How did Gunther Birznieks's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Gunther Birznieks has 0.
Where does Gunther Birznieks file Form 4?
Gunther Birznieks has filed Form 4 at VNDA (Vanda Pharmaceuticals Inc.) as SVP, Business Development. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.